BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Women&#039;s Canadian Club - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Women&#039;s Canadian Club
X-ORIGINAL-URL:https://www.womenscanadianclublondon.com
X-WR-CALDESC:Events for Women&#039;s Canadian Club
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20260212T140000
DTEND;TZID=America/Toronto:20260212T153000
DTSTAMP:20260507T061037
CREATED:20250514T201734Z
LAST-MODIFIED:20260423T225920Z
UID:3826-1770904800-1770910200@www.womenscanadianclublondon.com
SUMMARY:Dr. Michael Borrie
DESCRIPTION:Thank you to our Exclusive Event Sponsors (Joint)\, Lawson Research Institute and the Cognitive Clinical Research Group (CCRG) for your sponsorship of this event. \n \nAlzheimer Disease Biomarkers and New Disease Modifying Treatments \nMichael Borrie\, MB ChB\, FRCPC is a Geriatrician and Professor in the Department of Medicine\, Division of Geriatric Medicine\, The University of Western Ontario. \nHe is the Medical Director for the Aging Brain and Memory Clinic\, an investigator with the Cognitive Clinical Research Group (CCRG)\, Past President of the Consortium for Canadian Centres for Clinical Cognitive Research (C5R). \nHis research interests include investigator-initiated studies for predictors of conversion from mild cognitive impairment (MCI) to Alzheimer Disease (AD)\, including sensitive neuroimaging techniques\, blood and cerebral spinal fluid biomarkers. He is the platform lead for the Comprehensive Assessment of Neurodegeneration and Aging (COMPASS-ND) observational study of the Canadian Collaboration on Neurodegeneration in Aging (CCNA). \nSince 1995 the CCRG has been a leading Canadian research site conducting randomized controlled trials of new potential treatments for Subjective Cognitive Decline\, Mild Cognitive Impairment and Alzheimer’s disease.
URL:https://www.womenscanadianclublondon.com/event/dr-michael-borrie/
LOCATION:Best Western Plus Lamplighter Inn & Conference Centre\, 591 Wellington Rd. S.\, London\, Ont.\, N6C 4R3\, Canada
CATEGORIES:Past Speaker
ATTACH;FMTTYPE=image/jpeg:https://www.womenscanadianclublondon.com/wp-content/uploads/2025/05/MB-colour-1-scaled.jpg
END:VEVENT
END:VCALENDAR